default author photo

Qing-Qing Cai

Sun Yat-sen University (SYSU) - Department of Medical Oncology

651 Dongfeng Road East

Guangzhou, 510060

China

Prince of Wales Hospital - State Key Laboratory of Oncology in South China

China

Sun Yat-sen University (SYSU) - Collaborative Innovation Center for Cancer Medicine

Guangdong , 510060

China

SCHOLARLY PAPERS

2

DOWNLOADS

112

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Predictive Value of a CpG Methylation Classifier for Relapse in Adults with T-Cell Lymphoblastic Lymphoma: A Multicentre Study

Number of pages: 89 Posted: 29 Oct 2019
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Jinan University - College of Pharmacy, Southern Medical University, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Guangdong Academy of Medical Sciences, Government of the People's Republic of China - Department of Hematology, Sun Yat-sen University (SYSU) - Department of Medical OncologySun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Medical Oncology, Sun Yat-sen University (SYSU) - Department of Pathology, Sun Yat-sen University (SYSU) - Department of Pathology, Government of the People's Republic of China - First People's Hospital of Foshan, Government of the People's Republic of China - First People's Hospital of Foshan, Guangdong Academy of Medical Sciences - Guangdong General Hospital, Southern Medical University - Department of Pathology, Southern Medical University - Department of General Surgery, Sun Yat-sen University (SYSU) - Department of Hematology, Sun Yat-sen University (SYSU) - Department of Pathology, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, Sun Yat-sen University (SYSU) - Third Affiliated Hospital, Sun Yat-sen University (SYSU) - Third Affiliated Hospital, Tianjin Medical University - Cancer Institute and Hospital, Tianjin Medical University, Chinese Academy of Medical Sciences, Xi'an Jiaotong University (XJTU) - Key Laboratory for Physical Electronics and Devices of the Ministry of Education, Tianjin Medical University - Cancer Institute and Hospital, Guangzhou Medical University - First Affiliated Hospital, Guangzhou Medical University - First Affiliated Hospital, Jiangxi Cancer Hospital, Jiangxi Cancer Hospital, Government of the People's Republic of China - Department of Pathology, Southern Medical University - Shunde Hospital, Xuzhou Medical University, Xuzhou Medical University, Xuzhou Medical University, South China University of Technology - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Xinqiao Hospital, Jiangmen Central Hospital, Anhui Medical University - Department of General Surgery, Anhui Medical University, Anhui Provincial Cancer Hospital, Government of the People's Republic of China - First People’s Hospital of Dongguan, Guangdong Medical University - Department of Oncology, Guangdong Province Hospital for Women and Children, Sun Yat-sen University (SYSU) - Department of Medical Statistics and Epidemiology, Sun Yat-sen University (SYSU) - Cancer Center, Guangdong Pharmacology University - First Affiliated Hospital, Southern Medical University - Shunde Hospital, Huizhou Municipal Central Hospital, Jinan University - College of Pharmacy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - Department of Medical Oncology
Downloads 68 (891,180)

Abstract:

Loading...

CpG Methylation; Relapse; T-cell Lymphoblastic Lymphoma; LASSO; SVM-RFE

2.

Bortezomib in Combination with Fludarabine and Cyclophosphamide for Patients with Relapsed or Refractory Mantle-Cell Lymphoma: Results of the LYM-4003 Study

Number of pages: 75 Posted: 21 Aug 2019
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Zhejiang University - Department of Hematology, Fudan University - Department of Medical Oncology, Jiangsu Cancer Hospital - Department of Medical Oncology, Government of the People's Republic of China - Tianjin People's Hospital, Tianjin Cancer Hospital, Sun Yat-sen University (SYSU) - Department of Medical Oncology, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Medical OncologySun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Independent
Downloads 44 (1,145,425)

Abstract:

Loading...

bortezomib, fludarabine, cyclophosphamide, relapsed or refractory, mantle-cell lymphoma